• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe

Recalls

Boston Scientific recalls spinal cord stimulator leads after 1,081 serious injuries

September 4, 2026 By Skyler Rivera

Boston Scientific recalled all unused Infinion CX leads used in its spinal cord stimulator systems (SCS) after identifying an issue that could result in “high impedance measurements or lead fractures,” the company said. The company said the lead body could experience mechanical stress at the anchor site, which could cause the abnormal impedance measurements or […]

Filed Under: Featured, Food & Drug Administration (FDA), Implants, Pain Management, Recalls, Regulatory/Compliance, Spine Tagged With: Boston Scientific, spinal cord stimulation

Boston Scientific recalls, discontinues angiographic catheter sales

September 2, 2026 By Skyler Rivera

Boston Scientific recalled and discontinued all Imager II angiographic catheters due to a manufacturing issue, according to an FDA early alert. Imager II angiographic catheters are diagnostic intravascular catheters used to capture images of the patient’s peripheral vasculature. Boston Scientific determined the catheters were “manufactured with reduced levels of stabilizing agents in the tips,” according […]

Filed Under: Business/Financial News, Catheters, Diagnostics, Featured, Food & Drug Administration (FDA), News Well, Recalls, Regulatory/Compliance, Vascular Tagged With: Boston Scientific, catheter, recall

Medtronic recalls reflux testing system after 184 serious injuries

August 31, 2026 By Skyler Rivera

Medtronic initiated a global voluntary recall for certain lots of its Bravo calibration-free (CF) reflux testing system after reports of 184 serious injuries associated with a deployment control problem. Medtronic recalled the device “due to a risk of attachment and detachment issues related to the system’s delivery system,” a Medtronic spokesperson told MassDevice. “To ensure […]

Filed Under: Diagnostics, Endoscopic, Featured, Food & Drug Administration (FDA), News Well, Patient Monitoring, Recalls, Regulatory/Compliance Tagged With: Covidien, FDA, Given Imaging, Medtronic, recall

Johnson & Johnson’s Abiomed recalls Automated Impella Controllers after 3 patient deaths

August 27, 2026 By Skyler Rivera

Johnson & Johnson’s Abiomed recommends customers remove all Automated Impella Controllers (AICs) from where they’re used or sold after 37 reports of serious injuries and three deaths were linked to component failures. Abiomed identified purge cassette recognition issues “resulting from failures of the purge flag component within the purge pressure sensor assembly.” J&J issued the […]

Filed Under: Cardiovascular, Catheters, Featured, Food & Drug Administration (FDA), Recalls, Regulatory/Compliance, Structural Heart, Structural Heart Tagged With: Abiomed, Impella, Johnson & Johnson, Johnson & Johnson MedTech

FDA issues Class I recall for Hamilton Medical ventilator components

August 12, 2026 By Skyler Rivera

The FDA issued a Class 1 recall for certain Hamilton Medical coaxial breathing circuit sets after reports of four serious injuries. Hamilton Medical said certain lots of coaxial breathing circuit sets used with its Hamilton-C1, Hamilton T-1 and Hamilton-MR-1 ventilators are preassembled with an expiratory valve set that doesn’t perform as intended. “In some cases, […]

Filed Under: Business/Financial News, Featured, Food & Drug Administration (FDA), Recalls, Regulatory/Compliance, Respiratory Tagged With: FDA, Hamilton Medical, recall

BD recalls vascular access system needles after 4 patient deaths

August 3, 2026 By Skyler Rivera

Becton, Dickinson and Company (BD) issued a nationwide recall for specific lots of BD Intraosseous Vascular Access System Needle Sets after reports of four patient deaths. The FDA classified the recall as a Class I recall on August 17. A Class I recall is the agency’s most serious type of recall, in which use of […]

Filed Under: Drug-Device Combinations, Featured, Food & Drug Administration (FDA), News Well, Recalls, Regulatory/Compliance Tagged With: BD

FDA warns on percutaneous catheter issue from Boston Scientific

July 24, 2026 By Sean Whooley

The FDA today issued an early notice after Boston Scientific (NYSE:BSX) recommended the removal of certain percutaneous catheter systems. In a letter dated July 9, 2026, Boston Scientific told customers to identify affected EnRoute transcarotid neuroprotection system (NPS) and EnRoute NPS Plus products and cease use and distribution. Customers should return affected products to the […]

Filed Under: Catheters, Featured, Food & Drug Administration (FDA), Neurological, Recalls, Regulatory/Compliance, Vascular Tagged With: Boston Scientific, FDA

FDA issues early alert for certain Resmed Astral ventilators

July 16, 2026 By Sean Whooley

The FDA issued an early alert warning customers of potential issues with certain Resmed (NYSE:RMD) ventilator systems. In its communication, the FDA said Resmed issued a letter to affected customers recommending the correction of certain Astral 100 and Astral 150 ventilators as soon as replacement parts become available. Patients should not stop using the ventilator […]

Filed Under: Featured, Food & Drug Administration (FDA), Recalls, Regulatory/Compliance, Respiratory Tagged With: FDA, ResMed, ResMed Inc.

Medtronic warns on Harmony transcatheter pulmonary valve delivery system

July 13, 2026 By Sean Whooley

Medtronic (NYSE:MDT) has issued a letter to affected customers recommending the removal of certain lots of its Harmony delivery catheter system (DCS). In a notice published by the FDA, the agency said Medtronic’s recall involves removing certain devices from where they are used or sold. The FDA identified it as the most serious type, as […]

Filed Under: Cardiac Implants, Cardiovascular, Catheters, Featured, Food & Drug Administration (FDA), Implants, Recalls, Regulatory/Compliance, Replacement Heart Valves, Structural Heart, Structural Heart Tagged With: FDA, Medtronic

Terumo initiates voluntary thoracic stent graft recall after 3 deaths

July 1, 2026 By Sean Whooley

Terumo announced today that it initiated a voluntary recall of specific models of its Relay Pro thoracic stent graft system. Affected products include the Relay Pro NBS (non-bare stent) models with diameters ranging from 32 mm to 46 mm. The recall spans approximately 7,000 affected units sold between May 2024 and March 2026. Tokyo-based Terumo […]

Filed Under: Cardiovascular, Catheters, Endoscopic, Featured, Recalls, Regulatory/Compliance, Stent Grafts, Stents Tagged With: Terumo

Zoll faces FDA warning letter related to quality, reporting processes

June 17, 2026 By Sean Whooley

The FDA has issued Zoll Medical a warning letter outlining quality system regulation violations and violations of medical device reporting (MDR). An inspection of the Chelmsford, Massachusetts-based company from Feb. 27, 2025, through April 15, 2025, identified the violations, according to the FDA letter issued on April 30, 2026. Zoll develops a range of products, including […]

Filed Under: Cardiovascular, Featured, Food & Drug Administration (FDA), Hospital Care, Recalls, Regulatory/Compliance, Respiratory Tagged With: FDA, Zoll, Zoll Medical

  • Page 1
  • Page 2
  • Page 3
  • Interim pages omitted …
  • Page 124
  • Go to Next Page »

Primary Sidebar

Cart

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy